Determination of cefodizime in biological materials by high-performance liquid chromatography.
Cefodizime (THR-221) is a new semi-synthetic cephalosporin. A high-performance liquid chromatographic method has been developed for the determination of cefodizime in biological materials. A plasma or serum sample was deproteinized with methanol and the resulting methanol eluate was concentrated to a volume of 0.5 ml. Urine and bile samples were diluted with buffer and each diluted sample was filtered. Faeces samples were homogenized and the supernate obtained after centrifugation was filtered. Visceral tissue samples were homogenized, the centrifuged supernate was deproteinized with methanol, and the methanol eluate was concentrated to a volume of 0.5 ml. Aliquots of each preparation were chromatographed on a reversed-phase column with an ion-pair chromatographic technique on a high-performance liquid chromatograph equipped with an UV detector set at 264 nm. The detection limits for cefodizime were 0.1 microgram/ml in plasma or serum, 0.3 microgram/ml in bile, and 0.5 microgram/ml in urine, 0.5 microgram/g in faeces and visceral tissue. This precise and sensitive assay for the determination of cefodizime is described, and its stability in several media is reported.
Research Institute of Tokushima, Taiho Pharmaceutical Co., Ltd., Tokushima, Japan.
T
T
Marunaka
E
E
Matsushima
M
M
Maniwa
D000818:Animals; D002439:Cefotaxime / Q000031:analogs & derivatives* / Q000032:analysis / Q000097:blood / Q000652:urine; D002851:Chromatography, High Pressure Liquid; D004355:Drug Stability; D005243:Feces / Q000032:analysis; D006801:Humans; D007202:Indicators and Reagents; D051381:Rats
D007202:Indicators and Reagents; D002439:Cefotaxime; C033356:cefodizime